The Value Hunter

[The Value Hunter @TrueValueHunter]

$IBRX @DrPatrick best company ever!

[The Value Hunter @TrueValueHunter]

$IBRX Goldman Sachs buying, BlackRock buying and Vanguard buying. Squeeze is close $50 is coming.

[Top Stock Alerts @TopStockAlerts1]

$IBRX $8 - $12 will be fast!

[The Value Hunter @TrueValueHunter]

$ibrx will be 50$ soon with short squeeze.

[Divvy Daddy @BuffaloLatham]

$IBRX overseas route confirmed!
Wasting no time after locking up Kim to kick something off!

Unstoppable 🚀

[The Value Hunter @TrueValueHunter]

$IBRX will be $50 in a very short time.

[The Big Cheese @DuerigenSw68699]

$IBRX Institutions are LOADING, shrinking that free float. Retail owns about 5%

[The Value Hunter @TrueValueHunter]

@bullishbruk $IBRX will win!

[The Value Hunter @TrueValueHunter]

$IBRX will be $50 in a very short time.

[Bullish @bullishbruk]

$IBRX (Smart money) Institutional Ownership skyrocketed!
• 588 institutional owners/shareholders
• 242,234,780 shares held
Largest:
BlackRock, Inc, State Street Corp
Vanguard Portfolio Management LLC
Vanguard Capital Management LLC
D. E. Shaw & Co., Inc.
VTSMX – Vanguard Total Stock Market Index Fund, XBI – SPDR S&P Biotech ETF
NAESX – Vanguard Small-Cap Index Fund
Geode Capital Management, LLC
IWM – iShares Russell 2000 ETF.
@LoriMills4CA42 @alc2022

[The Value Hunter @TrueValueHunter]

$IBRX unstoppable!

[Dr. Pat Soon-Shiong @DrPatrick]

The unstoppable truth of scientific study. This figure in 1970s, our paper on NK in 1990s and now the path to the cure by understanding the power of our immune system. I have been obsessed by this image and this book for decades -the coffee stains as I read and reread & reread!

[The Value Hunter @TrueValueHunter]

$IBRX short squeeze will be soon. $50 price target.

[The Value Hunter @TrueValueHunter]

$IBRX Great results!!

[ImmunityBio, Inc. @ImmunityBio]

ImmunityBio reports Q2 2026 net product revenue up 92% to a record $50.7 million, marking the eighth consecutive quarter of sequential revenue growth since the commercial launch of ANKTIVA®, driven by continued adoption among U.S. urologists and strong market access. First-half 2026 net product revenue totaled $94.8 million, up 121% compared with the first half of 2025.

Access the full announcement: https://t.co/YheMMmCujQ

[The Value Hunter @TrueValueHunter]

$IBRX count down for $50 price target. It will be not in one day but it will be one day, soon!

[The Value Hunter @TrueValueHunter]

@NotA_Bull $IBRX

[The Value Hunter @TrueValueHunter]

Yes only a short time for short squeeze, target is $40. $IBRX

[The Value Hunter @TrueValueHunter]

$IBRX short squeeze is coming.

[GainzAlgo @gainzalgo]

Unconfirmed chatter suggests $IBRX Q2 sales landed near $60–63M, with Q3 potentially reaching $85M. Big acceleration if confirmed

[The Value Hunter @TrueValueHunter]

$IBRX

[The Big Cheese @DuerigenSw68699]

$IBRX Fun update today. The short interest has built back up to 134m, institutional ownership at a record high. You do the math!

[The Value Hunter @TrueValueHunter]

If $8 is the price now, a forced covering event against 0 liquidity will send this into price discovery.
$40 isn't a target; it's a byproduct of 132M shares chasing 0 sellers. 🚀 $IBRX

#IBRX #ShortSqueeze #MarketDynamics #TheValueHunter

[The Value Hunter @TrueValueHunter]

$40 is not a hype—it’s a mathematical inevitability. Let’s look at the cold, hard numbers. 🧵 $IBRX

[The Value Hunter @TrueValueHunter]

Historical precedent for supply-demand imbalance:
• Volkswagen (2008): Squeezed 5x.
• GameStop (2021): Squeezed 28x.

The IBRX supply-demand gap is arguably more severe than both. $IBRX

[The Value Hunter @TrueValueHunter]

I’m not playing for the squeeze; I’m playing for the 2030 future. But for those watching the charts: the shorts are sitting on a powder keg, and the fuse is burning shorter every single day. 💎🙌

#IBRX #Biotech #ShortSqueeze #ValueInvesting $IBRX

[The Value Hunter @TrueValueHunter]

The math behind the IBRX squeeze is screaming. 🧵

The float is ~290M shares, yet ~132M are held short. That’s nearly 45% of the float tied up in a losing battle. The shorts are trapped, and the setup is becoming explosive. 📈 $IBRX

[The Value Hunter @TrueValueHunter]

With 230M+ shares locked by institutional heavyweights, liquidity is drying up. When the cover begins, there won't be enough supply to satisfy the demand. It won't be a trade; it will be a stampede. 🐂 $IBRX